EWING SARCOMA OF BONE
Clinical trials for EWING SARCOMA OF BONE explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA OF BONE trials appear
Sign up with your email to follow new studies for EWING SARCOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young bone cancer patients: drug combo targets tough tumors
Disease control OngoingThis study tests the drug regorafenib in 30 patients aged 9 to 21 with bone cancers (osteosarcoma or Ewing sarcoma) that have not responded to standard therapy. The goal is to see if the drug can help control the disease and improve survival, while also checking its safety. The a…
Matched conditions: EWING SARCOMA OF BONE
Phase: PHASE1, PHASE2 • Sponsor: Institute of Mother and Child, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cancer drug regorafenib tested to halt bone sarcoma spread
Disease control OngoingThis phase 2 trial tests whether the drug regorafenib can stop or slow the growth of metastatic bone sarcomas (cancers that started in bone and spread). 163 patients with osteosarcoma, Ewing sarcoma, chondrosarcoma, or chordoma are randomly assigned to receive regorafenib or a pl…
Matched conditions: EWING SARCOMA OF BONE
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC
-
Blood test could revolutionize sarcoma monitoring
Knowledge-focused OngoingThis study is testing whether a liquid biopsy (a blood test that detects tumor DNA) can help predict outcomes for people with Ewing sarcoma or osteosarcoma. Researchers will collect blood samples from 340 patients at diagnosis and track their health over time. The goal is to see …
Matched conditions: EWING SARCOMA OF BONE
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC